BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9886785)

  • 1. Differing acute interactions of ethanol with two structurally related dihydropyridines, nitrendipine and felodipine.
    Watson WP; Homewood N; Little HJ
    Brain Res Bull; 1998 Nov; 47(4):337-43. PubMed ID: 9886785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dihydropyridines on the components of the ethanol withdrawal syndrome: possible evidence for involvement of potassium, as well as calcium?
    Watson WP; Little JJ
    Alcohol Clin Exp Res; 1997 May; 21(3):409-16. PubMed ID: 9161599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The differential effects of felodipine and nitrendipine on cerebral dihydropyridine binding ex vivo and the ethanol withdrawal syndrome in mice.
    Watson WP; Misra A; Cross AJ; Green AR; Little HJ
    Br J Pharmacol; 1994 Aug; 112(4):1017-24. PubMed ID: 7524989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic dihydropyridine treatment can reverse the behavioural consequences of and prevent adaptations to, chronic ethanol treatment.
    Whittington MA; Dolin SJ; Patch TL; Siarey RJ; Butterworth AR; Little HJ
    Br J Pharmacol; 1991 Jul; 103(3):1669-76. PubMed ID: 1834295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivity of the protective effects of dihydropyridine calcium channel antagonists against the ethanol withdrawal syndrome.
    Watson WP; Little HJ
    Brain Res; 2002 Mar; 930(1-2):111-22. PubMed ID: 11879801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between diltiazem and ethanol: differences from those seen with dihydropyridine calcium channel antagonists.
    Watson WP; Little HJ
    Psychopharmacology (Berl); 1994 Mar; 114(2):329-36. PubMed ID: 7838926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydropyridine-sensitive calcium channels and barbiturate tolerance and withdrawal.
    Rabbani M; Brown J; Butterworth AR; Little HJ
    Pharmacol Biochem Behav; 1994 Mar; 47(3):675-80. PubMed ID: 8208788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are changes in neuronal calcium channels involved in ethanol tolerance?
    Dolin SJ; Little HJ
    J Pharmacol Exp Ther; 1989 Sep; 250(3):985-91. PubMed ID: 2570870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prolonged exposure to ethanol in vivo on functional parameters and sensitivity to nitrendipine in the isolated rat heart.
    Guppy LJ; Littleton JM
    J Cardiovasc Pharmacol; 1999 Sep; 34(3):414-9. PubMed ID: 10471001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a self-modeling curve resolution method for studying the photodegradation kinetics of nitrendipine and felodipine.
    Javidnia K; Hemmateenejad B; Miri R; Saeidi-Boroujeni M
    J Pharm Biomed Anal; 2008 Feb; 46(3):597-602. PubMed ID: 18164160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant effects of calcium antagonists on rat myocardial membrane lipid peroxidation.
    Sugawara H; Tobise K; Kikuchi K
    Hypertens Res; 1996 Dec; 19(4):223-8. PubMed ID: 8986452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrendipine blocks the nociceptive effects of chronically administered ethanol.
    Gatch MB
    Alcohol Clin Exp Res; 2002 Aug; 26(8):1181-7. PubMed ID: 12198392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of "nitrendipine" on nitrous oxide anesthesia, tolerance, and physical dependence.
    Dolin SJ; Little HJ
    Anesthesiology; 1989 Jan; 70(1):91-7. PubMed ID: 2521437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrendipine prevents the decrease caused by chronic ethanol intake in the maintenance of tetanic long-term potentiation.
    Ripley TL; Little HJ
    Exp Brain Res; 1995; 103(1):1-8. PubMed ID: 7615026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential interactions between benzodiazepines and the dihydropyridines, nitrendipine and Bay K 8644.
    Dolin SJ; Patch TL; Rabbani M; Taberner PV; Little HJ
    Neuropharmacology; 1991 Mar; 30(3):217-24. PubMed ID: 1712926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dihydropyridine calcium channel antagonists in ethanol withdrawal; doses required, stereospecificity and actions of Bay K 8644.
    Littleton JM; Little HJ; Whittington MA
    Psychopharmacology (Berl); 1990; 100(3):387-92. PubMed ID: 1690434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermal stability of 1,4-dihydropyridine derivatives in solid state.
    Marciniec B; Ogrodowczyk M
    Acta Pol Pharm; 2006; 63(6):477-84. PubMed ID: 17438863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation by calcium channel antagonists of general anaesthetic potency in mice.
    Dolin SJ; Little HJ
    Br J Pharmacol; 1986 Aug; 88(4):909-14. PubMed ID: 2943355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between increases in dihydropyridine binding in vivo and behavioural signs of ethanol withdrawal in mice.
    Watson WP; Little HJ
    Alcohol Alcohol; 1999; 34(1):35-42. PubMed ID: 10075399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of a dihydropyridine calcium channel antagonist on the components of ethanol tolerance.
    Smith JW; Little HJ
    Brain Res; 2000 Apr; 863(1-2):9-19. PubMed ID: 10773188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.